Liver biopsy

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 6 SUPPL. 1, 2008, Pages 4-7

  Bedossa, P ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Biopsy; Extracellular matrix; Histopathology; METAVIR; Sampling variation

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; EXTRACELLULAR MATRIX; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; MEDICAL RESEARCH; OUTCOME ASSESSMENT; VIRUS HEPATITIS;

BIOPSY; HUMANS; LIVER; LIVER CIRRHOSIS;

EID: 54349116714     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(08)73989-7     Document Type: Article

References (25)

1. Menghini G. One-second needle biopsy of the liver. Gastroenterology 35 (1958) 190-199
2. Cadranel J.F., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32 (2000) 477-481
3. Piccinino F., Sagnelli E., Pasquale, and Giusti G. Complications following percutaneous liver biopsy a multicentre retrospective study on 68276 biopsies. J Hepatol 2 (1986) 165-173
4. McGill D.B., Rakela J., Zinsmeister A.R., and Ott J.B. A 21 year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 99 (1990) 1396-1409
5. Actis G.C., Olivero A., Lagget M., Pellicano R., Smedile A., and Rizzetto M. The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies. Dig Dis Sci 52 (2007) 2576-2579
6. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
7. Guido M., and Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 24 (2004) 89-97
8. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 (1994) 15-20
9. Bedossa P., Dargère D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
10. Colloredo G., Guido M., and Sonzogni ALeandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
11. Westin J., Lagging L.M., Wejstål R., Norkrans G., and Dhillon A.P. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 19 (1999) 183-187
12. Goldin R.D., Goldin J.G., Burt A.D., Dhillon P.A., Hubscher S., Wyatt J., et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 25 (1996) 649-654
13. Rousselet M.C., Michalak S., Dupré F., Croué A., Bedossa P., Saint-André J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
14. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981) 431-435
15. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
16. Bedossa P., and The METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis. Hepatology 24 (1996) 289-293
17. Fontaine H., Petitprez K., Roudot-Thoraval F., and Trinchet J.C. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 31 (2007) 504-509
18. Standish R.A., Cholongitas E., Dhillon A., Burroughs A.K., and Dhillon A.P. An appraisal of the histopathological assessment of liver fibrosis. Gut 55 (2006) 569-578
19. Masseroli M., Caballero T., O'Valle F., Del Moral R.M., Pérez-Milena A., and Del Moral R.G. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 32 (2000) 453-464
20. Goodman Z.D., Becker Jr. R.L., Pockros P.J., and Afdhal N.H. Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology 45 (2007) 886-894
21. Fartoux L., Chazouillères O., Wendum D., Poupon R., and Serfaty L. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41 (2005) 82-87
22. Bedossa P., Moucari R., Chelbi E., Asselah T., Paradis V., Vidaud M., et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology 46 (2007) 380-387
23. Cisneros L., Londoño M.C., Blasco C., Bataller R., Miquel R., Bruguera M., et al. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in nontransplanted patients with chronic hepatitis C. Liver Transpl 13 (2007) 1017-1027
24. Gawrieh S., Papouchado B.G., Burgart L.J., Kobayashi S., Charlton M.R., and Gores G.J. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl 11 (2005) 1207-1213
25. Asselah T., Bieche I., Narguet S., Sabbagh A., Laurendeau I., Ripault M.P., et al. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut 57 (2008) 516-524